Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06151587 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Phase 3 Clinical Study of QLM3004 in Delaying Myopia in Children

StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated November 30, 2023 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Efficacy and Safety Study of QLM3004 in Myopic Children
Trial Details
NCT Number NCT06151587
Lead Sponsor Qilu Pharmaceutical Co., Ltd.
Conditions Myopia
Enrollment 735 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov